Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,746 | -2,421 | -141 | -150 | -329 |
| Depreciation Amortization | 311 | 123 | N/A | N/A | N/A |
| Accounts receivable | 412 | -534 | N/A | N/A | N/A |
| Other Working Capital | 291 | 159 | 0 | 3 | -394 |
| Other Operating Activity | 1,526 | 924 | 4 | 0 | -66 |
| Operating Cash Flow | $-3,206 | $-1,749 | $-137 | $-147 | $-789 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -552 | N/A | 1,217 |
| PPE Investments | -844 | -1,291 | N/A | 0 | N/A |
| Other Investing Activity | -59 | -45 | 61 | 38 | 97 |
| Investing Cash Flow | $-903 | $-1,336 | $-492 | $39 | $1,314 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 800 | N/A | N/A | N/A |
| Debt Repayment | -1,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 8,373 | 2,546 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -45 | 0 | 0 | 0 |
| Financing Cash Flow | $7,373 | $3,301 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 1,477 | 1,261 | 808 | 916 | 391 |
| End Cash Position | 4,741 | 1,477 | 180 | 808 | 916 |
| Net Cash Flow | $3,264 | $216 | $-628 | $-108 | $525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,206 | -1,749 | -137 | -147 | -789 |
| Capital Expenditure | -844 | -1,291 | N/A | N/A | N/A |
| Free Cash Flow | -4,050 | -3,040 | -137 | -147 | -789 |